Join Growin Stock Community!

Optimizerx corporationOPRX.US Overview

US StockHealthcare
(No presentation for OPRX)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

OPRX AI Insights

OPRX Overall Performance

OPRX AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

OPRX Recent Performance

-2.77%

Optimizerx corporation

0.05%

Avg of Sector

-0.31%

S&P500

OPRX PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

OPRX Key Information

OPRX Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

OPRX Profile

OptimizeRx Corporation, a digital health technology company, provides various solutions to life sciences organizations, healthcare providers, and patients. The company's products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems; and brand awareness and therapeutic support messaging services, such as brand awareness messages, reminder ads, and therapeutic support and unbranded messages. It also offers brand support services, which focuses on educating and working with pharmaceutical manufacturers on identifying, formulating, and implementing eRx media strategies, including drug file integration, sales force training, and strategy development services for promoting their products. In addition, the company operates cloud based Mobile Health Messenger platform that provides interactive health messaging for enhanced medication adherence and care coordination; and HIPAA-compliant automated mobile messaging platform, which allows pharmaceutical manufactures and related entities to directly engage with patients to enhance regimen compliance. Further, it offers patient programs with treatment and affordability information, lifestyle and condition trackers, internet device connectivity, forms, and surveys. Additionally, the company provides evidence-based physician engagement solution applied to real-world data to assist healthcare providers in identifying patients who may be qualified for specific therapies, raise awareness of patient access pathways, and identify early indicators of non-adherence among patient populations. It also offers therapy initiation workflow focused on accelerating patient access to treatments where time-consuming medical documentation is required of HCPs prior to pharmacies dispensing prescribed drugs. The company was found in 2006 and is headquartered in Rochester, Michigan.

Price of OPRX

OPRX FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

OPRX Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.00
PE Ratio (TTM)
758.00
Forward PE
11.77
PS Ratio (TTM)
1.29
PB Ratio
1.20
Price-to-FCF
11.91
METRIC
VALUE
vs. INDUSTRY
Gross Margin
65.31%
Net Margin
0.03%
Revenue Growth (YoY)
24.18%
Profit Growth (YoY)
29.57%
3-Year Revenue Growth
20.00%
3-Year Profit Growth
22.97%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
0.00
PE Ratio (TTM)
758.00
Forward PE
11.77
PS Ratio (TTM)
1.29
PB Ratio
1.20
Price-to-FCF
11.91
Gross Margin
65.31%
Net Margin
0.03%
Revenue Growth (YoY)
24.18%
Profit Growth (YoY)
29.57%
3-Year Revenue Growth
20.00%
3-Year Profit Growth
22.97%

  • When is OPRX's latest earnings report released?

    The most recent financial report for Optimizerx corporation (OPRX) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating OPRX's short-term business performance and financial health. For the latest updates on OPRX's earnings releases, visit this page regularly.

  • Where does OPRX fall in the P/E River chart?

    According to historical valuation range analysis, Optimizerx corporation (OPRX)'s current price-to-earnings (P/E) ratio is 8,580.18, placing it in the Value zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of OPRX?

    According to the latest financial report, Optimizerx corporation (OPRX) reported an Operating Profit of 2.05M with an Operating Margin of 7.86% this period, representing a growth of 123.94% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is OPRX's revenue growth?

    In the latest financial report, Optimizerx corporation (OPRX) announced revenue of 26.07M, with a Year-Over-Year growth rate of 22.33%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does OPRX have?

    As of the end of the reporting period, Optimizerx corporation (OPRX) had total debt of 28.61M, with a debt ratio of 0.17. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does OPRX have?

    At the end of the period, Optimizerx corporation (OPRX) held Total Cash and Cash Equivalents of 19.52M, accounting for 0.11 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does OPRX go with three margins increasing?

    In the latest report, Optimizerx corporation (OPRX) achieved the “three margins increasing” benchmark, with a gross margin of 67.2%%, operating margin of 7.86%%, and net margin of 3%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess OPRX's profit trajectory and future growth potential.

  • Is OPRX's EPS continuing to grow?

    According to the past four quarterly reports, Optimizerx corporation (OPRX)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.04. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of OPRX?

    Optimizerx corporation (OPRX)'s Free Cash Flow (FCF) for the period is 3.19M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 87.88% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of OPRX?

    The latest valuation data shows Optimizerx corporation (OPRX) has a Price-To-Earnings (PE) ratio of 8,580.18 and a Price/Earnings-To-Growth (PEG) ratio of -2.36. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.